Clik here to view.
Tocagen’s Double Action Glioblastoma Treatment Receives FDA Orphan Drug...
Toca 511 and Toca FC, developed by Tocagen, is a combination treatment currently being investigated in phase I/II trials for recurrent high grade glioma including the notoriously difficult to treat...
View ArticleClik here to view.
China Generic Drugmakers Poaching Indian Execs
China Generic Drugmakers Poaching Indian Execs Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott. In the competition between China and India pharmas, China’s generic drug industry...
View ArticleClik here to view.
Indian pharma’s struggle to tighten standards paves way for M&A deals
People walk past a chemist shop at a market in Mumbai. Photo: Reuters MUMBAI – India’s smaller generic drugmakers, struggling to cope with a bruised reputation and tougher regulation in the United...
View ArticleClik here to view.
Chi-Med Says Fruquintinib Successful in Lung Cancer Trial
Fruquintinib Phase 3…cancer Hutchison Medipharma Enterprises Limited Hutchison MediPharma for the treatment of locally advanced or metastatic colorectal cancer C21H19N3O5 Exact Mass: 393.1325 cas...
View ArticleClik here to view.
Dr. Jeffrey Kiplinger at Averica Discovery Services, Speeding Discovery into...
Jeffrey Kiplinger Averica Discovery Services President & CEO at Averica Discovery Services Speeding Discovery into Development links jeff.kiplinger@avericadiscovery.com...
View ArticleClik here to view.
WO 2015129603, NEW PATENT, Daiichi Sankyo Co Ltd, Edoxaban
WO 2015129603 HIGH-PURITY CRYSTALS OF ACTIVE BLOOD COAGULATION FACTOR X (FXA) INHIBITOR DAIICHI SANKYO COMPANY,LIMITED [JP/JP]; 3-5-1,Nihonbashi Honcho,Chuo-ku, Tokyo 1038426 (JP) Claims highly...
View ArticleClik here to view.
EU: New GMP Implementing Act published
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: The EU Commission has published a new public consultation on an Implementing Act on GMP principles and guidelines for medicinal products for...
View ArticleClik here to view.
IPI-926, Saridegib
C29H48N2O3S Exact Mass: 504.33856 Saridegib also known as IPI-926 is an experimental drug candidate undergoing clinical trials for the treatment of various types of cancer, including hard to treat...
View ArticleClik here to view.
Ombitasvir
Ombitasvir; ABT-267; ABT 267; UNII-2302768XJ8; 1258226-87-7; C50H67N7O8 Molecular Weight: 894.10908 g/mol Anti-Viral Compounds [US2010317568] Dimethyl...
View ArticleClik here to view.
GSK 1059615
GSK1059615; 958852-01-2; GSK-1059615; UNII-07YMO87363; GSK 615 (5Z)-5-[(4-pyridin-4-ylquinolin-6-yl)methylidene]-1,3-thiazolidine-2,4-dione...
View ArticleClik here to view.
GSK1904529A, GSK 4529
GSK1904529A, GSK 4529 GSK1904529A is a selective inhibitor of IGF1R with IC50 of 27 nM. 851.96 Formula C44H47F2N9O5S CAS Number 1089283-49-7...
View ArticleClik here to view.
Actual Interpretation of the GMP Requirements for Active Pharmaceutical...
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: Actual Interpretation of the GMP Requirements for Active Pharmaceutical Ingredients: APIC revises the “How to do” Document on ICH Q7 The...
View ArticleClik here to view.
ARTEMISININ
Artemisinin is a sesquiterpene lactone with an endoperoxide function. It was first isolated from the Chinese traditional herb—Artemisia annua L. and its structure was first confirmed by Chinese...
View ArticleClik here to view.
Beijing Shenogen Granted Fast Track Status for Novel Cancer Drug, Icaritin
Icaritin; 118525-40-9; AC1NSXIV; UNII-UFE666UELY; 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one...
View ArticleClik here to view.
Gnidia glauca
Gnidia glauca Introduction Search of complementary and alternative medicine has gained a thrust in the recent decade due to the pronounced side effects and health hazards of the chemically synthesized...
View ArticleClik here to view.
As of September 2015, updated Requirements apply to the Application of a CEP!
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: As of September 2015, updated Requirements apply to the Application of a CEP! The EDQM recently revised its certification policy. Read more...
View ArticleClik here to view.
Chlorzoxazone
Chlorzoxazone Chlorzoxazone; Paraflex; Chlorzoxazon; Myoflexin; Solaxin; 95-25-0; 5-chloro-3H-1,3-benzoxazol-2-one A centrally acting central muscle relaxant with sedative properties. It is claimed to...
View ArticleClik here to view.
Improved one-pot synthesis of N,...
Tolterodine is chemically known as (R)-N,N-disiopropyl-3-(2-hydroxy-5-methyl phenyl)-3-phenyl propyl amine. Tolterodine acts as a muscarinic receptor antagonist. It is useful in the treatment of...
View ArticleClik here to view.
GSK2334470
GSK2334470 GSK2334470; 1227911-45-6; GSK-2334470; GSK 2334470; (3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide...
View ArticleClik here to view.
Wockhardt, WO 2015136473, sodium (2S,...
WO-2015136473 https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2015136473&redirectedID=true WOCKHARDT LIMITED [IN/IN]; D-4, MIDC Area, Chikalthana, Aurangabad 431006 (IN) Our New Drug...
View Article